Goldman-Backed Heart Valve Startup Is Said to Mull Hong Kong IPO

Venus MedTech, a Chinese developer of heart valve replacements backed by Goldman Sachs Group Inc., is considering a Hong Kong initial public offering, people with knowledge of the matter said. Venus, …
( read original story …)

---